CONVERSION LABS, INC. Stock Agreements
20 Contracts & Agreements
- Restricted Stock Award Agreement, dated April 26, 2024, between LifeMD, Inc. and Calum MacRae (Filed With SEC on May 2, 2024)
- Restricted Stock Award Agreement dated November 13, 2023 between Justin Schreiber and LifeMD, Inc (Filed With SEC on November 14, 2023)
- Restricted Stock Award Agreement dated July 26, 2023 between Nicholas Alvarez and LifeMD, Inc (Filed With SEC on November 8, 2023)
- Restricted Stock Award Agreement dated June 13, 2023 between Brad Roberts and LifeMD, Inc (Filed With SEC on August 9, 2023)
- Restricted Stock Award Agreement dated July 11, 2023 between Marc Benathen and LifeMD, Inc (Filed With SEC on July 14, 2023)
- Non-Qualified Stock Option Agreement, dated June 20, 2023, between LifeMD, Inc. and William J. Febbo (Filed With SEC on June 22, 2023)
- Restricted Stock Award Agreement, dated June 20, 2023, between LifeMD, Inc. and William J. Febbo (Filed With SEC on June 22, 2023)
- Restricted Stock Award Agreement between Jessica Friedeman and LifeMD, Inc. dated January 3, 2023 (Filed With SEC on March 22, 2023)
- Non-Qualified Stock Option Agreement, dated February 9, 2023, between LifeMD, Inc. and Joan LaRovere (Filed With SEC on February 10, 2023)
- Restricted Stock Award Agreement, dated February 9, 2023, between LifeMD, Inc. and Joan LaRovere (Filed With SEC on February 10, 2023)
- Amendment to Stock Purchase Agreement, dated as of February 4, 2023 (Filed With SEC on February 10, 2023)
- Non-Qualified Stock Option Agreement, dated December 15, 2022, between LifeMD, Inc. and Kate Walsh (Filed With SEC on December 21, 2022)
- Restricted Stock Award Agreement, dated December 15, 2022, between LifeMD, Inc. and Kate Walsh (Filed With SEC on December 21, 2022)
- Non-Qualified Stock Option Agreement, dated September 14, 2022, between LifeMD, Inc. and Robert Jindal (Filed With SEC on September 20, 2022)
- Restricted Stock Award Agreement, dated September 14, 2022, between LifeMD, Inc. and Robert Jindal (Filed With SEC on September 20, 2022)
- Stock Option Pledge Agreement, dated as of February 12, 2022, by and between Fitzpatrick Consulting LLC and LifeMD, Inc (Filed With SEC on February 22, 2022)
- Stock Purchase Agreement, dated as of January 11, 2022 (Filed With SEC on January 12, 2022)
- Certificate of Designation of Series A Preferred Stock (Filed With SEC on October 4, 2021)
- Non-Qualified Stock Option Agreement by and between the Company and Alexander Mironov, dated June 10, 2021 (Filed With SEC on August 13, 2021)
- Form of Restricted Stock Award Agreement (Filed With SEC on January 14, 2021)